Stem cell therapy holds the promise to treat diseases for which there are currently no or only limited therapeutic options. Christine Mummery,…

The Netherlands provides a flourishing environment for biotech to grow. The vice president for European operations at Kite Pharma discusses how…

Winner of the Dutch Prix Corona Gallina in 2011, Prof. Dr. Bart Roep discusses his groundbreaking research into type 1 diabetes; his wishes to deal…

OrganoPlates™ serve as a highly useable platform for 3D cell cultures, are completely compatible with existing lab equipment, and can be used to…

The founder of MEDIPOST, the producer of the only approved allogenic stem cell product in the world, disucsses their development goals for the coming…

David Malta and Daniela Couto, Co-founders of Cell2B, discuss the company’s origins and plans to achieve market authorization, and what makes the…

The chairman of Bionet reflects on past market challenges and the growing strength of Bionet’s reach both domestically and globally, and why Taiwan…

The Chairman of Taiwan Advance Bio-Pharmaceutical Inc. discusses the challenges and opportunities TABP has faced in its transformation into a…

Thank you for having us today to give our readers an overview of the capabilities and contribution of NICE in the UK. Dr Richard Barker of ABPI has…